Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting.

Chambers TJ, Tsai TF, Pervikov Y, Monath TP.

Vaccine. 1997 Oct;15(14):1494-502. No abstract available.

PMID:
9330458
2.

From the World Health Organization. Development of dengue and Japanese encephalitis vaccines.

Brandt WE.

J Infect Dis. 1990 Sep;162(3):577-83. No abstract available.

PMID:
1696952
3.

Concepts of control of Japanese encephalitis and dengue.

Shope RE.

Southeast Asian J Trop Med Public Health. 1997;28 Suppl 2:131-4.

PMID:
9561649
4.

Vaccines aplenty.

Halstead SB.

Curr Opin Infect Dis. 2002 Oct;15(5):461-3. Review. No abstract available.

PMID:
12686876
5.
7.

Protection against Japanese encephalitis by inactivated vaccines.

Hoke CH, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, Innis BL, Kotchasenee S, Gingrich JB, Latendresse J, Fukai K, et al.

N Engl J Med. 1988 Sep 8;319(10):608-14.

PMID:
2842677
8.

Technology evaluation: ChimeriVax-DEN, Acambis/Aventis.

Jones T.

Curr Opin Mol Ther. 2004 Aug;6(4):443-50.

PMID:
15468603
9.

[Dengue, a growing problem of health in the Americas].

Kourí G.

Rev Panam Salud Publica. 2006 Mar;19(3):143-5. Spanish. No abstract available.

PMID:
16640842
10.

Editorial: the challenge of dengue vaccine development and introduction.

Deen JL.

Trop Med Int Health. 2004 Jan;9(1):1-3. No abstract available.

PMID:
14728601
11.

Dengue virus: break-bone fever.

Clarke T.

Nature. 2002 Apr 18;416(6882):672-4. No abstract available.

PMID:
11961522
12.

Dengue and yellow fever--challenges for the development and use of vaccines.

Monath TP.

N Engl J Med. 2007 Nov 29;357(22):2222-5. No abstract available.

13.

[Dengue and dengue hemorrhagic fever: research priorities].

Guzmán MG, García G, Kourí G.

Rev Panam Salud Publica. 2006 Mar;19(3):204-15. Review. Spanish.

PMID:
16640849
14.

Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand.

Hombach J, Barrett AD, Cardosa MJ, Deubel V, Guzman M, Kurane I, Roehrig JT, Sabchareon A, Kieny MP.

Vaccine. 2005 Apr 15;23(21):2689-95.

PMID:
15841565
15.

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.

Monath TP, Soike K, Levenbook I, Zhang ZX, Arroyo J, Delagrave S, Myers G, Barrett AD, Shope RE, Ratterree M, Chambers TJ, Guirakhoo F.

Vaccine. 1999 Apr 9;17(15-16):1869-82.

PMID:
10217584
16.

Dengue vaccine design: issues and challenges.

Cardosa MJ.

Br Med Bull. 1998;54(2):395-405. Review.

PMID:
9830205
17.

Tropical diseases. Hunt for dengue vaccine heats up as the disease burden grows.

Normile D.

Science. 2007 Sep 14;317(5844):1494-5. No abstract available.

PMID:
17872423
18.

A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available.

Ishikawa T, Yamanaka A, Konishi E.

Vaccine. 2014 Mar 10;32(12):1326-37. doi: 10.1016/j.vaccine.2014.01.040. Epub 2014 Jan 29. Review.

PMID:
24486372
19.

Chimeric Japanese encephalitis virus/dengue 2 virus infectious clone: biological properties, immunogenicity and protection against dengue encephalitis in mice.

Chambers TJ, Jiang X, Droll DA, Liang Y, Wold WS, Nickells J.

J Gen Virol. 2006 Nov;87(Pt 11):3131-40.

PMID:
17030845
20.

Vaccine prospects for dengue haemorrhagic fever.

[No authors listed]

World Health Forum. 1993;14(2):203. No abstract available.

PMID:
8185774

Supplemental Content

Support Center